This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Novaicos Immunotherapeutics S.r.l.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Chiara Dianzani: Innovator in Anti-Tumor Therapeutics
Introduction
Chiara Dianzani is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of immunotherapy, particularly in the development of anti-tumor agents. Her innovative work focuses on harnessing the potential of B7h receptor ligands to combat cancer.
Latest Patents
Chiara Dianzani holds a patent for "Anti-tumor therapeutic agents based on B7h receptor ligands." This patent describes novel anti-tumor agents that comprise at least one ligand of the B7h receptor. The ligands are loaded in a biocompatible micro- or nano-carrier, enabling them to bind to the B7h receptor and trigger its activity. This innovative approach has the potential to enhance therapeutic outcomes in cancer treatment.
Career Highlights
Chiara Dianzani is associated with Novaicos Immunotherapeutics S.r.l., where she continues to advance her research in immunotherapy. Her work has garnered attention for its potential to revolutionize cancer treatment through targeted therapeutic strategies.
Collaborations
Chiara collaborates with notable colleagues, including Umberto Dianzani and Annalisa Chiocchetti. Their combined expertise contributes to the innovative research and development efforts at Novaicos Immunotherapeutics S.r.l.
Conclusion
Chiara Dianzani is a trailblazer in the field of anti-tumor therapeutics, with her patent and ongoing research promising to make a significant impact in cancer treatment. Her dedication to innovation and collaboration highlights the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile